Connor, Clark & Lunn Investment Management »

Amneal Pharmaceuticals shares owned by Connor, Clark & Lunn Investment Management

Quarter-by-quarter ownership of Amneal Pharmaceuticals (AMRX) shares owned by Connor, Clark & Lunn Investment Management from 13F filings

Historical chart of Connor, Clark & Lunn Investment Management investment in Amneal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amneal Pharmaceuticals held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amneal Pharmaceuticals by Connor, Clark & Lunn Investment Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $6.2M 623k 10.01
2025-06-30 $4.9M 603k 8.09
2025-03-31 $4.4M 528k 8.38
2024-12-31 $4.4M 556k 7.92
2024-09-30 $4.6M 549k 8.32
2024-06-30 $3.5M 558k 6.35
2024-03-31 $3.2M 533k 6.06
2023-12-31 $2.9M 477k 6.07
2023-09-30 $2.1M 492k 4.22
2023-06-30 $1.2M 385k 3.10
2023-03-31 $459k 331k 1.39
2022-12-31 $466k 234k 1.99
2022-09-30 $310k 154k 2.02
2020-09-30 $70k 18k 3.89
2020-06-30 $1.4M 299k 4.76
2020-03-31 $634k 182k 3.48